Peter J. Selby

Active 1978–2024

129
Papers
21,747
Citations
87
h-index
127
i10-index

Citations

Citations per year for Peter J. Selby1948: 3 citations1980: 2 citations1981: 6 citations1982: 12 citations1983: 9 citations1984: 3 citations1985: 2 citations1987: 4 citations1988: 4 citations1989: 11 citations1990: 10 citations1991: 7 citations1992: 17 citations1993: 15 citations1994: 24 citations1995: 41 citations1996: 48 citations1997: 37 citations1998: 66 citations1999: 70 citations2000: 78 citations2001: 90 citations2002: 81 citations2003: 101 citations2004: 147 citations2005: 165 citations2006: 147 citations2007: 154 citations2008: 147 citations2009: 201 citations2010: 165 citations2011: 202 citations2012: 188 citations2013: 167 citations2014: 186 citations2015: 149 citations2016: 148 citations2017: 155 citations2018: 183 citations2019: 495 citations2020: 623 citations2021: 513 citations2022: 382 citations2023: 266 citations2024: 441 citations2025: 186 citations2026: 3 citations1949–1979: no citations, so these years are not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,081 citing papers, 23.4% of this breakdownUnited Kingdom: 1,031 citing papers, 11.6% of this breakdownChina: 557 citing papers, 6.3% of this breakdownGermany: 480 citing papers, 5.4% of this breakdownCanada: 476 citing papers, 5.4% of this breakdownItaly: 376 citing papers, 4.2% of this breakdownNetherlands: 356 citing papers, 4% of this breakdownFrance: 330 citing papers, 3.7% of this breakdownAustralia: 301 citing papers, 3.4% of this breakdownSpain: 229 citing papers, 2.6% of this breakdownSweden: 178 citing papers, 2% of this breakdownJapan: 176 citing papers, 2% of this breakdown
0%23.4%Other 26%

Fields

  • Medicine57.7%
  • Biochemistry, Genetics and Molecular Biology26.5%
  • Chemistry4.8%
  • Immunology and Microbiology3.3%
  • Health Professions2.4%
  • Psychology1%
  • Other4.3%

Topics

  • Cancer survivorship and care5.3%
  • Multiple Myeloma Research and Treatments3.1%
  • Virus-based gene therapy research3.1%
  • CAR-T cell therapy research2.6%
  • Immunotherapy and Immune Responses2%
  • Advanced Proteomics Techniques and Applications2%
  • Other81.9%

Coauthors

All papers

Open in search
  1. The prevalence and outcomes of frailty in older cancer patients: a systematic review

    Authors: , , , , , , - Annals of Oncology 2014 cited by 1,030

  2. Suspension trapping (STrap) sample preparation method for bottom‐up proteomics analysis

    Authors: , , - PROTEOMICS 2014 cited by 458

  3. Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled Trial

    Authors: , , , , , , - Journal of Clinical Oncology 2004 cited by 1,407

  4. Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fiona Errington‐Mais, Hardev Pandha, Kevin J. Harrington, Peter J. Selby, Richard G. Vile, Stephen Griffin, Lucy F. Stead, Susan Short, Alan Melcher - Science Translational Medicine 2018 cited by 377

  5. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Teodora Kolarova, Tezer Kutluk, Grant Lewison, Françoise Meunier, Jana Pelouchová, Thierry Philip, Richard Price, Beate Rau, Isabel T. Rubio, Peter J. Selby, Maja Južnič Sotlar, Gilliosa Spurrier‐Bernard, Jolanda C. van Hoeve, Eduard Vrdoljak, Willien Westerhuis, Urszula Wojciechowska, Richard Sullivan - The Lancet Oncology 2022 cited by 105

  6. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith Carser, Gopalakrishnan Srinivasan, Fiona Thistlewaite, Ashraf Azzabi, Mark Beresford, David Farrugia, M. Decatris, Carys Thomas, Joanna Gale, James J McAleer, Alison Clayton, Ekaterini Boleti, T. Geldart, Santhanam Sundar, J.F. Lester, Nachi Palaniappan, Mohan Hingorani, Khaliq Rehman, Mohammad Adil Khan, Naveed Sarwar, Janine Graham, Alastair Thomson, Narayanan Srihari, Denise Sheehan, R. Srinivasan, Omar Khan, Andrew Stockdale Jane Worlding, Stergios Boussios, N Stuart, Carey MacDonald-Smith, Falalu Danwata, Duncan McLaren, Aravindhan Sundaramurthy, Anna Lydon, S. Beesley, Kathryn Lees, Mohini Varughese, Emma Gray, Angela Scott, Mark Baxter, Anna Mullard, Pasquale F. Innominato, Gaurav Kapur, Anil Kumar, Natalie Charnley, Caroline Manetta, Prabir Chakraborti, Prantik Das, Sarah Rudman, Henry F. Taylor, Christos Mikropoulos, Martin Highley, D. Muthukumar, Anjali Zarkar, Roy Vergis, Seshadri Sriprasad, Patryk Brulinski, Amanda Clarke, Richard Osbourne, Melanie Harvey, Renata Dega, Geoffrey Sparrow, U. Barthakur, Erica Beaumont, Caroline Manetta, Agnieszka Michael, Emilio Porfiri, Faisal Azam, Ravi Kodavtiganti - The Lancet Oncology 2023 cited by 81

  7. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer

    Authors: , , , , , , , , , , , , , , , - BMJ Open 2020 cited by 176

  8. The Value and Future Developments of Multidisciplinary Team Cancer Care

    Authors: , , , , - American Society of Clinical Oncology Educational Book 2019 cited by 168

  9. Proteomic analysis of melanoma‐derived exosomes by two‐dimensional polyacrylamide gel electrophoresis and mass spectrometry

    Authors: , , , , , , , , - PROTEOMICS 2004 cited by 333

  10. Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2012 cited by 193

  11. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

    Authors: , , , , , , , , - New England Journal of Medicine 2003 cited by 1,765

  12. Radiofrequency ablation ( RFA ) of renal cell carcinoma ( RCC ): experience in 200 tumours

    Authors: , , , , , - British Journal of Urology 2013 cited by 221

  13. Variation in genomic landscape of clear cell renal cell carcinoma across Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jiří Zavadil, Jing Su, Ivana Holcátová, A. Brisuda, Давид Заридзе, Anush Moukeria, Lenka Foretová, Marie Navrátilová, Dana Mateș, Viorel Jinga, Artem V. Artemov, Artem Nedoluzhko, Alexander M. Mazur, Sergey Rastorguev, Eugenia Boulygina, Simon Heath, Marta Gut, Marie‐Thérèse Bihoreau, Doris Lechner, Mario Foglio, Marta Gut, K. G. Skryabin, Egor Prokhortchouk, Anne Cambon‐Thomsen, Johan Rung, Guillaume Bourque, Paul Brennan, Jörg Tost, Rosamonde E. Banks, Alvis Brāzma, G.M. Lathrop - Nature Communications 2014 cited by 200

  14. Measles virus causes immunogenic cell death in human melanoma

    Authors: , , , , , , , , , , , , , , - Gene Therapy 2011 cited by 186

  15. High hospital research participation and improved colorectal cancer survival outcomes: a population-based study

    Authors: , , , , , , , , , , , , , , , - Gut 2016 cited by 170

  16. Genome-wide association study identifies multiple risk loci for renal cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lenka Foretová, Ivana Holcátová, Vladimí­r Janout, Dana Mateș, Anush Mukeriya, Ștefan Rașcu, Давид Заридзе, Vladimír Bencko, Cezary Cybulski, Eleonóra Fabiánová, Viorel Jinga, Jolanta Lissowska, Jan Lubiński, Marie Navratilova, Péter Rudnai, Neonila Szeszenia‐Dąbrowska, Simone Benhamou, Géraldine Cancel‐Tassin, Olivier Cussenot, Laura Baglietto, Heiner Boeing, Kay‐Tee Khaw, Elisabete Weiderpass, Börje Ljungberg, Raviprakash T. Sitaram, Fiona Bruinsma, Susan J. Jordan, Gianluca Severi, Ingrid Winship, Kristian Hveem, Lars J. Vatten, Tony Fletcher, Kvetoslava Koppová, Susanna C. Larsson, Alicja Wolk, Rosamonde E. Banks, Peter J. Selby, Douglas F. Easton, Paul D.P. Pharoah, Gabriella Andreotti, Laura E. Beane Freeman, Stella Koutros, Demetrius Albanes, Satu Männistö, Stephanie J. Weinstein, Peter E. Clark, Todd L. Edwards, Loren Lipworth, Susan M. Gapstur, Victoria L. Stevens, Hallie Carol, Matthew L. Freedman, Mark M. Pomerantz, Eunyoung Cho, Peter Kraft, Mark A. Preston, Kathryn M. Wilson, J. Michael Gaziano, Howard D. Sesso, Amanda Black, Neal D. Freedman, Wen‐Yi Huang, John Anema, Richard J. Kahnoski, Brian R. Lane, Sabrina L. Noyes, David Petillo, Bin Tean Teh, Ulrike Peters, Emily White and 23 more - Nature Communications 2017 cited by 140

  17. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis

    Authors: , , , , , , , , - British Journal of Cancer 2013 cited by 189

  18. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 145

  19. Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2011 cited by 98

  20. The European Code of Cancer Practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Cancer Policy 2021 cited by 48

  21. Proteomics: new perspectives, new biomedical opportunities

    Authors: , , , , , , - The Lancet 2000 cited by 451

  22. Skeletal complications and survival in renal cancer patients with bone metastases

    Authors: , , , , , , , , , - Bone 2010 cited by 192

  23. Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

    Authors: , , , , , , , , , , , , , - Clinical Cancer Research 2009 cited by 177

  24. Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming

    Authors: , , , , , , , , , , - British Journal of Cancer 2005 cited by 127